Innovative technology in wound dressings：Suzhou Bioactivx
Burns injuries are fairly common in China with official statistics reporting up to 23 million burn injuries in 2023 alone. Burn wounds are particularly susceptible to bacterial infections leading to complications that include sepsis and death. Traditional collagen dressings, while somewhat effective in alleviating patient pain, pose a risk of bacterial infection and can easily lead to scarring.
Suzhou Bioactivx Medical Technology Co., Ltd. is an innovative material platform company that focuces on addressing skin issues using synthetic acellular active materials. Dr Peili Teo, one of the founders, graduated from the National University of Singapore and pursued further studies at the California Institute of Technology. She conducted postdoctoral research under Nobel Laureate Professor Robert H. Grubbs. With over 20 years of research experience in chemical synthesis, material chemistry, and medical technology, Dr Teo currently leads Suzhou Bioactivx's technical research and product development.
Suzhou Bioactivx's core technology lies in its bioactive polymers, which utilises advanced organic chemical synthesis to link oligopeptides targeted at specific cells in the body to synthetic polymers. By blending this active material with biocompatible base polymers, formulations can be created for use in various medical device and therapeutics production. Bioactivx's flagship product is a skin substitute that utilises this core technology. The skin substitute is 3D Printed to create porous sheets that are breathable and water permeable. Compared to traditional dressings made from animal collagen, Suzhou Bioactivx's unique synthetic materials significantly reduce the risk of bacterial infection and scarring potential.
